Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
SARS-CoV-2 스파이크 단백질 변이체에 의한 중화 항체로부터의 탈출
Research Article
[키워드] activate
addressed
Administered
Analysis
anti-SARS-CoV-2
antibodies
antibody
antibody combination
antibody-based therapies
antibody-based therapy
Blood
blood plasma
cause
Cell
cells
changed
chimeric
circulating
Combination
convalescent plasma
coronavirus
COVID-19
COVID19
creating
effective vaccine
Effective vaccines
Effectiveness
effort
elicited
eLife
Epitopes
escape
evade
Frequency
functional
Genome
Health
HIV
host cells
Human
human cells
human population
human populations
immune
immune response
immune system
in some
individual
infect
Infection
Influenza
kill
Laboratory
limit
low frequencies
maintain
monoclonal antibodies
monoclonal antibody
mutant
mutant virus
mutate
mutated
Mutation
N-terminal domain
natural infection
neutralize
Neutralizing antibodies
neutralizing antibody
neutralizing epitopes
New coronavirus
Patient
Population
populations
Prevent
produced
Prophylactic
Proteins
question
RBD
Receptor-binding domain
Recovered COVID-19 patients
reporter
Research
SARS-CoV-2
SARS-CoV-2 genome
SARS-CoV-2 genomes
SARS-CoV-2 S
SARS-CoV-2 S protein
SARS-CoV-2 spike protein
SARS-CoV-2 variant
selected
Sequencing
Spike protein
Spike proteins
Structure
structures
target
the antibody
the disease
the receptor-binding domain
the SARS-CoV-2
the spike protein
the strongest
therapeutic
Therapies
treated
Trigger
vaccination
Vaccine
Vaccines
variant
Viral protein
Viral proteins
virus
virus mutation
virus particle
virus particles
viruses
VSV
were infected
[DOI] 10.7554/eLife.61312 PMC 바로가기 [Article Type] Research Article
[DOI] 10.7554/eLife.61312 PMC 바로가기 [Article Type] Research Article